Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03456544|
Recruitment Status : Recruiting
First Posted : March 7, 2018
Last Update Posted : August 28, 2019
|Condition or disease||Intervention/treatment|
|Vancomycin Staphylococcal Infections Adverse Effect Acute Kidney Injury Cross-sectional Study||Drug: Vancomycin|
|Study Type :||Observational|
|Estimated Enrollment :||10000 participants|
|Official Title:||Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China|
|Actual Study Start Date :||October 31, 2018|
|Estimated Primary Completion Date :||October 31, 2019|
|Estimated Study Completion Date :||December 31, 2019|
Patients who had vancomycin associated acute kidney injury.
Patients who have vancomycin associated acute kidney injury will be in the Van-AKI group, and those who don't have vancomycin associated acute kidney injury will be in the none VAN-AKI group.
Patients who didn't have vancomycin associated acute kidney injury.
- Vancomycin-associated acute kidney injury(VAN-AKI) occuration rate [ Time Frame: 1 year ]
- VAN-AKI detection rate [ Time Frame: 1 year ]
- TDM detction rate [ Time Frame: 1 year ]
- 0h Serum creatinine detction rate [ Time Frame: 1 year ]
- 48h Serum creatinine detction rate [ Time Frame: 1 year ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03456544
|Contact: Lingyun Maemail@example.com|
|Peking University First Hospital||Recruiting|
|Beijing, Beijing, China, 100034|
|Contact: Lingyun Ma 008601066110802 firstname.lastname@example.org|